NeoGenomics will break ground in late 2019 on a $55 million oncology laboratory and global headquarters facility in Fort Myers, Fla. Designed by Studio Plus, the 150,000-sf facility will provide the comprehensive cancer diagnostics company with research and administrative space for up to 575 employees. Located on a 14-acre parcel, the building will support clinical trials of new oncology therapeutics with a state-of-the-art molecular lab with next-generation sequencing capabilities. The project team includes Hole Montes as civil engineer and Smith, Seckman, Reid as MEP engineer. Seagate Development Group is the construction manager, site contractor, and developer. Occupancy is expected by year-end 2021.